FDA clears Abbott's blood test for concussion
Abbott (NYSE:ABT) received FDA clearance for the first commercially available laboratory traumatic brain injury (TBI) blood test.
Source: massdevice.com
📰 Alinityi Abbott News
Alinityi Abbott News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alinityi Abbott. Real-time updates on events, politics, business and more.